1 / 21

Risk Management & Real Options IX. Flexibility in Contracts

Risk Management & Real Options IX. Flexibility in Contracts. Stefan Scholtes Judge Institute of Management University of Cambridge MPhil Course 2004-05. Introduction The forecast is always wrong The industry valuation standard: Net Present Value Sensitivity analysis

bin
Download Presentation

Risk Management & Real Options IX. Flexibility in Contracts

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Risk Management & Real OptionsIX. Flexibility in Contracts Stefan Scholtes Judge Institute of Management University of Cambridge MPhil Course 2004-05

  2. Introduction The forecast is always wrong The industry valuation standard: Net Present Value Sensitivity analysis The system value is a shape Value profiles and value-at-risk charts SKILL: Using a shape calculator CASE:Overbooking at EasyBeds Developing valuation models Easybeds revisited Designing a system means sculpting its value shape CASE: Designing a Parking Garage I The flaw of averages: Effects of system constraints Coping with uncertainty I: Diversification The central limit theorem The effect of statistical dependence Optimising a portfolio Coping with uncertainty II: The value of information SKILL:Decision Tree Analysis CASE: Market Research at E-Phone Coping with uncertainty III: The value of flexibility Investors vs. CEOs CASE: Designing a Parking Garage II The value of phasing SKILL: Lattice valuation Example: Valuing a drug development projects The flaw of averages: The effect of flexibility Hedging: Financial options analysis and Black-Scholes Contract design in the presence of uncertainty SKILL:Two-party scenario tree analysis Project: Valuing a co-development contract Course content © Scholtes 2004

  3. Co-development contracts: Risk Sharing • Contracts are the building blocks of business • Example: Co-development contracts between biotech & pharma • Exploit core competencies, IP • Share responsibilities • Share required capital • Share risk • Further example: Production sharing contracts between BP and national oil company © Scholtes 2004

  4. Co-development contracts: Risk Sharing • Risk in a phased project: • Technical risk of phase failures • Long lead time until revenues occur • Market risk after launch • Typical contract terms: • Investment split • Share capital commitment • Milestone payments upon successful phase completions • Reward for taking technical risk • Royalty payments (e.g. % of sales revenue) • Share market risk • What is the effect of payment terms on contract value? © Scholtes 2004

  5. Co-development contracts: Control • Two parties take downstream decisions to cut losses and amplify gains • Contract specifies feasible actions through “control structure” • Loosing control increases exposure to risk and lowers the contract value • Cure: Understand the interest of the partner and incentivise through contract terms to take actions in your interest • Maintaining or gaining control increases value • What is the effect of the control structure on contract value? © Scholtes 2004

  6. 2-Phase example 2 Phase example • Development phase • Sales phase Let’s value this first as a 100% in-house project © Scholtes 2004

  7. Taking downstream decisions into account © Scholtes 2004

  8. Taking downstream decisions into account “Market uncertainty level” © Scholtes 2004

  9. The effect of uncertainty From here NPV at launch is negative in downside scenario: Cut downside – profit from upside © Scholtes 2004

  10. Co-development contract • Biotech does not have sufficient cash and expertise to launch • Search for large pharma company to co-develop • Contract negotiated on the following basis • 50/50 split of development costs • After development, project goes to pharma for sales against milestone / royalty payments for biotech • What should the milestone / royalty terms be? © Scholtes 2004

  11. Co-development contract • Traditional approach: • “We are carrying 50% of the development costs, so we want 50% of the product value if and when it is developed” • Estimated value at time of launch: $100-$80=$20 • Construct the deal so that its total value to biotech in case of successful development is $10 • Suggestion • $5 upon successful completion of development • 5% royalty on sales = 0.05*$100=$5 © Scholtes 2004

  12. Value of the deal • Value of the deal, taking account of other party’s downstream decisions Launch and get Revenue – launch cost– royalties- milestone Don’t launch and pay milestone © Scholtes 2004

  13. The effect of uncertainty © Scholtes 2004

  14. The effect of uncertainty © Scholtes 2004

  15. The effect of different royalty rates • Market uncertainty level 10% • Contract terms: 10% or revenues but no milestone payment • Biotech argues that it wants more than 50/50 since it is the opportunity seller © Scholtes 2004

  16. The effect of different royalty rates • Market uncertainty level 10% • Contract terms: 10% or revenues but no milestone payment • Biotech argues that it wants more than 50/50 since it is the opportunity seller © Scholtes 2004

  17. The effect of different royalty rates • Market uncertainty level 10% • Contract terms: 10% or revenues but no milestone payment • Biotech argues that it wants more than 50/50 since it is the opportunity seller GREED CAN DESTROY VALUE © Scholtes 2004

  18. The effect of different royalty rates • Market uncertainty level 10% • Contract terms: 10% or revenues but no milestone payment • Biotech argues that it wants more than 50/50 since it is the opportunity seller © Scholtes 2004

  19. Summary • Gaining or maintaining control has significant value • Launch decision • Milestones and royalties have different associated risks • Milestone payments are sunk at time of launch and have no impact on launch decision • Increasing royalties gives disincentive to launch and can destroy total value of co-development deal © Scholtes 2004

  20. Key messages • Traditional valuation techniques have severe limitations when applied to the valuation of multi-stage projects • Need to take downstream flexibility into account • Have seen Monte Carlo simulation and scenario tree approaches • Effect is magnified in contract valuation • Need to take account of your own as well as your contract partner’s flexibility • Need to understand incentives provided by contract terms • Have seen how scenario tree approach can be used © Scholtes 2004

  21. Introduction The forecast is always wrong The industry valuation standard: Net Present Value Sensitivity analysis The system value is a shape Value profiles and value-at-risk charts SKILL: Using a shape calculator CASE:Overbooking at EasyBeds Developing valuation models Easybeds revisited Designing a system means sculpting its value shape CASE: Designing a Parking Garage I The flaw of averages: Effects of system constraints Coping with uncertainty I: Diversification The central limit theorem The effect of statistical dependence Optimising a portfolio Coping with uncertainty II: The value of information SKILL:Decision Tree Analysis CASE: Market Research at E-Phone Coping with uncertainty III: The value of flexibility Investors vs. CEOs CASE: Designing a Parking Garage II The value of phasing SKILL: Lattice valuation Case: Valuing a drug development projects The flaw of averages: The effect of flexibility Hedging: Financial options analysis and Black-Scholes (not covered) Contract design in the presence of uncertainty SKILL:Two-party scenario tree analysis Case: Valuing a co-development contract Wrap-up and conclusions Course content © Scholtes 2004

More Related